Holocene Advisors, LP Jazz Pharmaceuticals PLC Transaction History

Holocene Advisors, LP

$38 Billion
Q2 2025

A detailed history of Holocene Advisors, LP transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Holocene Advisors, LP holds 469,742 shares of JAZZ stock, worth $65.5 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

469,742

Previous 492,029 4.53%

Holding current value

$65.5 Million

Previous $61.1 Million 18.39%

% of portfolio

0.13%

Previous 0.19%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$97.78 - $126.44 $2.18 Million - $2.82 Million	-22,287 Reduced 4.53%	469,742 $49.8 Million
Q1 2025 May 15, 2025	BUY	$120.07 - $144.17 $59.1 Million - $70.9 Million	492,029 New	492,029 $61.1 Million
Q2 2021 Aug 16, 2021	SELL	$160.2 - $186.42 $694,146 - $807,757	-4,333 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$150.19 - $173.5 $100 Million - $116 Million	-667,236 Reduced 99.35%	4,333 $712,000
Q4 2020 Feb 16, 2021	SELL	$140.71 - $165.05 $21.4 Million - $25.1 Million	-151,833 Reduced 18.44%	671,569 $111 Million
Q3 2020 Nov 16, 2020	BUY	$105.46 - $144.13 $35.9 Million - $49.1 Million	340,749 Added 70.6%	823,402 $117 Million
Q2 2020 Aug 14, 2020	BUY	$95.68 - $121.88 $1.47 Million - $1.88 Million	15,404 Added 3.3%	482,653 $53.3 Million
Q1 2020 May 15, 2020	BUY	$87.74 - $152.74 $26.2 Million - $45.6 Million	298,775 Added 177.34%	467,249 $46.6 Million
Q4 2019 Feb 14, 2020	BUY	$117.65 - $153.73 $19.8 Million - $25.9 Million	168,474 New	168,474 $25.2 Million
Q2 2018 Aug 14, 2018	SELL	$146.33 - $183.18 $241,298 - $302,063	-1,649 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$135.59 - $157.16 $416,532 - $482,795	-3,072 Reduced 65.07%	1,649 $249,000
Q4 2017 Feb 14, 2018	BUY	$131.06 - $150.39 $618,734 - $709,991	4,721	4,721 $636,000

Others Institutions Holding JAZZ

# of Institutions

562

Shares Held

62.7M

Call Options Held

563K

Put Options Held

77.8K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $8.74B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

News

Stay updated on Holocene Advisors, LP with notifications on news.

Account

Holocene Advisors, LP Jazz Pharmaceuticals PLC Transaction History